Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KNSA |
---|---|---|
09:32 ET | 2119 | 25.31 |
09:39 ET | 100 | 25.51 |
09:41 ET | 400 | 25.51 |
09:45 ET | 1120 | 24.89 |
09:48 ET | 2034 | 25.095 |
09:50 ET | 600 | 25.1 |
09:54 ET | 100 | 25.225 |
09:56 ET | 100 | 25.1 |
09:57 ET | 945 | 25.11 |
10:01 ET | 2100 | 25.195 |
10:03 ET | 400 | 25.195 |
10:06 ET | 3985 | 25.385 |
10:08 ET | 1300 | 25.385 |
10:10 ET | 200 | 25.29 |
10:12 ET | 100 | 25.385 |
10:14 ET | 1458 | 25.385 |
10:15 ET | 100 | 25.48 |
10:17 ET | 1200 | 25.57 |
10:19 ET | 100 | 25.54 |
10:21 ET | 500 | 25.63 |
10:24 ET | 656 | 25.675 |
10:26 ET | 900 | 25.73 |
10:28 ET | 1803 | 25.615 |
10:30 ET | 6300 | 25.5 |
10:32 ET | 1895 | 25.5 |
10:33 ET | 695 | 25.49 |
10:35 ET | 600 | 25.46 |
10:37 ET | 1024 | 25.475 |
10:39 ET | 770 | 25.455 |
10:42 ET | 900 | 25.43 |
10:44 ET | 400 | 25.47 |
10:46 ET | 700 | 25.49 |
10:48 ET | 628 | 25.49 |
10:50 ET | 530 | 25.44 |
10:51 ET | 400 | 25.51 |
10:53 ET | 2600 | 25.495 |
10:55 ET | 1000 | 25.4 |
10:57 ET | 110 | 25.405 |
11:00 ET | 531 | 25.38 |
11:02 ET | 500 | 25.3 |
11:04 ET | 2234 | 25.39 |
11:06 ET | 400 | 25.36 |
11:08 ET | 100 | 25.36 |
11:09 ET | 100 | 25.445 |
11:11 ET | 300 | 25.41 |
11:13 ET | 1318 | 25.41 |
11:15 ET | 100 | 25.37 |
11:20 ET | 100 | 25.43 |
11:24 ET | 300 | 25.37 |
11:26 ET | 1975 | 25.525 |
11:27 ET | 100 | 25.525 |
11:29 ET | 100 | 25.525 |
11:31 ET | 200 | 25.525 |
11:33 ET | 993 | 25.58 |
11:36 ET | 329 | 25.53 |
11:38 ET | 100 | 25.61 |
11:40 ET | 200 | 25.61 |
11:42 ET | 400 | 25.64 |
11:44 ET | 500 | 25.62 |
11:45 ET | 1299 | 25.53 |
11:47 ET | 166 | 25.5824 |
11:49 ET | 200 | 25.48 |
11:51 ET | 342 | 25.44 |
11:54 ET | 100 | 25.44 |
11:58 ET | 400 | 25.37 |
12:00 ET | 400 | 25.3 |
12:02 ET | 300 | 25.29 |
12:03 ET | 400 | 25.29 |
12:05 ET | 200 | 25.3 |
12:07 ET | 733 | 25.298 |
12:09 ET | 400 | 25.27 |
12:12 ET | 400 | 25.24 |
12:14 ET | 200 | 25.275 |
12:18 ET | 400 | 25.29 |
12:21 ET | 100 | 25.29 |
12:23 ET | 2040 | 25.3 |
12:25 ET | 500 | 25.25 |
12:27 ET | 700 | 25.22 |
12:30 ET | 700 | 25.37 |
12:32 ET | 400 | 25.31 |
12:36 ET | 500 | 25.37 |
12:38 ET | 404 | 25.39 |
12:39 ET | 300 | 25.34 |
12:41 ET | 100 | 25.35 |
12:43 ET | 300 | 25.33 |
12:45 ET | 600 | 25.29 |
12:48 ET | 2840 | 25.42 |
12:50 ET | 1068 | 25.38 |
12:52 ET | 100 | 25.32 |
12:54 ET | 200 | 25.25 |
12:56 ET | 412 | 25.235 |
12:57 ET | 431 | 25.17 |
01:01 ET | 300 | 25.19 |
01:06 ET | 1000 | 25.22 |
01:08 ET | 600 | 25.17 |
01:10 ET | 300 | 25.23 |
01:12 ET | 600 | 25.24 |
01:14 ET | 2109 | 25.24 |
01:15 ET | 336 | 25.21 |
01:17 ET | 400 | 25.2 |
01:19 ET | 600 | 25.25 |
01:21 ET | 300 | 25.29 |
01:24 ET | 400 | 25.3 |
01:26 ET | 300 | 25.29 |
01:30 ET | 200 | 25.28 |
01:33 ET | 600 | 25.28 |
01:35 ET | 400 | 25.26 |
01:37 ET | 207 | 25.28 |
01:39 ET | 750 | 25.275 |
01:42 ET | 400 | 25.25 |
01:44 ET | 500 | 25.25 |
01:46 ET | 200 | 25.195 |
01:48 ET | 800 | 25.18 |
01:50 ET | 200 | 25.245 |
01:51 ET | 400 | 25.3 |
01:53 ET | 1700 | 25.33 |
01:55 ET | 1202 | 25.345 |
01:57 ET | 748 | 25.33 |
02:00 ET | 200 | 25.31 |
02:02 ET | 500 | 25.345 |
02:04 ET | 400 | 25.31 |
02:06 ET | 200 | 25.37 |
02:08 ET | 200 | 25.36 |
02:09 ET | 400 | 25.345 |
02:11 ET | 300 | 25.33 |
02:13 ET | 200 | 25.32 |
02:15 ET | 1130 | 25.3 |
02:18 ET | 100 | 25.3 |
02:20 ET | 803 | 25.31 |
02:22 ET | 419 | 25.29 |
02:24 ET | 500 | 25.28 |
02:26 ET | 200 | 25.33 |
02:27 ET | 876 | 25.35 |
02:29 ET | 900 | 25.28 |
02:31 ET | 300 | 25.23 |
02:33 ET | 700 | 25.28 |
02:38 ET | 700 | 25.325 |
02:42 ET | 700 | 25.325 |
02:44 ET | 1100 | 25.31 |
02:45 ET | 200 | 25.33 |
02:47 ET | 1532 | 25.36 |
02:49 ET | 2300 | 25.31 |
02:51 ET | 188 | 25.28 |
02:54 ET | 500 | 25.27 |
02:56 ET | 700 | 25.28 |
02:58 ET | 448 | 25.285 |
03:00 ET | 300 | 25.26 |
03:02 ET | 995 | 25.25 |
03:03 ET | 800 | 25.32 |
03:05 ET | 500 | 25.28 |
03:07 ET | 1207 | 25.25 |
03:12 ET | 300 | 25.25 |
03:14 ET | 100 | 25.25 |
03:16 ET | 715 | 25.34 |
03:18 ET | 200 | 25.37 |
03:20 ET | 800 | 25.31 |
03:21 ET | 914 | 25.26 |
03:23 ET | 903 | 25.215 |
03:25 ET | 803 | 25.14 |
03:27 ET | 2256 | 25.26 |
03:30 ET | 700 | 25.28 |
03:32 ET | 500 | 25.25 |
03:34 ET | 1428 | 25.25 |
03:36 ET | 703 | 25.27 |
03:38 ET | 903 | 25.25 |
03:39 ET | 1400 | 25.28 |
03:41 ET | 1492 | 25.28 |
03:43 ET | 1200 | 25.23 |
03:45 ET | 1143 | 25.15 |
03:48 ET | 1400 | 25.25 |
03:50 ET | 1200 | 25.19 |
03:52 ET | 1400 | 25.22 |
03:54 ET | 1500 | 25.275 |
03:56 ET | 4601 | 25.31 |
03:57 ET | 2133 | 25.35 |
03:59 ET | 41488 | 25.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kiniksa Pharmaceuticals Ltd | 1.8B | -142.0x | --- |
CareDx Inc | 1.6B | -10.1x | --- |
Zai Lab Ltd | 2.1B | -6.8x | --- |
MannKind Corp | 1.8B | 182.9x | --- |
BioCryst Pharmaceuticals Inc | 1.6B | -10.8x | --- |
Dynavax Technologies Corp | 1.5B | 111.4x | --- |
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8B |
---|---|
Revenue (TTM) | $338.9M |
Shares Outstanding | 71.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.33 |
EPS | $-0.18 |
Book Value | $6.23 |
P/E Ratio | -142.0x |
Price/Sales (TTM) | 5.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -8.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.